Jardines announces half-year results and 2030 commitments
Financial highlights show improved free cash flow and dividend, along with strategic targets including at least 9% TSR per annum.
See the latest news and media coverage for Jardines. We track all announcements, press releases, and industry mentions in real time, all in one place.
Diversified Asia-focused investment company
jardines.comLast updated
In short: Jardines reported an 11% increase in 2025 profit, transitioned to an investment company model, and acquired I-MED Radiology for $2.4 billion.
Financial highlights show improved free cash flow and dividend, along with strategic targets including at least 9% TSR per annum.
He will lead investment activities in Indonesia and join the executive leadership team, reporting to CEO Lincoln Pan.
The plan includes targets through 2030, a US$500 million buyback, and a focus on control ownership.
The deal includes I-MED's minority stake in Harrison.ai and is expected to close later in 2026.
Board declares interim dividend of US$0.65 per share; full-year dividend targeted to grow 5% to US$2.47 apiece Read more at The Business Times.
Jardine Matheson declared an interim dividend of 65 US cents per share, up 8% from 60 cents. Looking ahead, the company upgraded its full-year dividend...
Hongkong Land, the property arm of the billionaire Keswick family's Jardine Matheson, has planned a $1 billion revamp of its flagship luxury retail portfolio located...
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks...
Track Jardines and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Jardines and other trending companies.